Valuation: Virbac

Market Cap 2.93B 3.33B 2.72B 2.51B 4.7B 323B 4.78B 32.57B 12.71B 157B 12.52B 12.25B 546B P/E 2026 *
17.2x
P/E 2027 * 15.5x
Enterprise Value 3.06B 3.48B 2.84B 2.61B 4.9B 337B 4.99B 33.98B 13.25B 164B 13.06B 12.78B 570B EV / Sales 2026 *
1.97x
EV / Sales 2027 * 1.83x
Free-Float
49.03%
Yield 2026 *
0.49%
Yield 2027 * 0.58%
1 day-4.43%
1 week+2.45%
Current month+0.60%
1 month-0.30%
3 months-11.62%
6 months-7.98%
Current year-6.43%
1 week 323
Extreme 323
350
1 month 312.5
Extreme 312.5
350
Current year 312.5
Extreme 312.5
389.5
1 year 296
Extreme 296
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 31/08/2025
Chief Executive Officer 50 26/09/2024
Chief Operating Officer 64 31/12/2021
Director TitleAgeSince
Chairman 61 31/03/2006
Director/Board Member 68 27/07/2010
Director/Board Member 65 04/09/2017
Date Insider Type Main position Quantity % Market Cap.
22/04/24 Sell

Chief Executive Officer

1,688 0.0200%
22/04/24 Sell

Chief Executive Officer

810 0.0096%
22/04/24 Sell

Chief Executive Officer

140 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-4.43%+2.45%-7.60%+24.35% 3.35B
-0.30%-3.78%-51.78%-60.13% 31.1B
-2.51%-4.47%+65.05%+105.73% 12.66B
+1.84%+5.45%-19.46%+1.84% 3.72B
+2.30%-5.32%+32.72%+12.78% 1.82B
-1.62%+2.76%-10.80%+23.71% 1.86B
-0.25%-2.11%+13.43%+124.07% 1.37B
+1.01%-1.29%-24.79%-13.46% 1.07B
+0.78%-0.77%-17.26%-47.86% 968M
-1.26%-2.61%-7.57%-21.68% 951M
Average -0.42%+1.90%-2.81%+14.93% 5.89B
Weighted average by Cap. -0.77%+0.66%-14.90%-4.88%

Financials

2026 *2027 *
Net sales 1.55B 1.76B 1.44B 1.32B 2.48B 171B 2.53B 17.22B 6.72B 83.24B 6.62B 6.47B 289B 1.65B 1.87B 1.53B 1.41B 2.64B 181B 2.69B 18.29B 7.13B 88.43B 7.03B 6.88B 307B
Net income 171M 195M 159M 146M 274M 18.84B 279M 1.9B 742M 9.19B 730M 715M 31.89B 190M 216M 176M 162M 304M 20.91B 310M 2.11B 823M 10.2B 811M 793M 35.39B
Net Debt 127M 144M 118M 108M 203M 13.96B 207M 1.41B 549M 6.81B 541M 529M 23.62B 75.16M 85.46M 69.82M 64.22M 120M 8.28B 123M 835M 326M 4.04B 321M 314M 14B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
23/07/26 334.50 -4.43% 5,064
22/07/26 €350.00 +2.34% 7,395
21/07/26 €342.00 +5.07% 19,650
20/07/26 €325.50 -0.15% 4,243
17/07/26 €326.00 -0.15% 3,635
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
350.00EUR
Average target price
412.00EUR
Spread / Average Target
+17.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock